FGF21 and atherosclerosis: Also, further prospective studies are needed to clarify whether FGF21 can be used as a predictive biomarker to identify individuals at high risk of atherosclerosis in atherosclerosis‐associated diseases and whether FGF21 therapy can reduce the risk of atherosclerosis in these diseases.